The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Danny Rischin receives institutional research funding from MSD, Bristol–Myers Squibb, GSK and Roche. He participates in trial steering committees and/or advisory boards (all uncompensated) for MSD, GSK, Regeneron and Sanofi.